ChartMill assigns a Buy % Consensus number of 84% to VTVT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-05 | TD Cowen | Initiate | Buy |
| 2025-12-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-19 | BTIG | Initiate | Buy |
| 2025-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-09 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-09 | Alliance Global Partners | Initiate | Buy |
| 2023-03-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-17 | Northland Capital Markets | Maintains | Outperform |
| 2022-02-18 | Cantor Fitzgerald | Initiate | Overweight |
9 analysts have analysed VTVT and the average price target is 41.48 USD. This implies a price increase of 13.83% is expected in the next year compared to the current price of 36.44.
The consensus rating for VTV THERAPEUTICS INC- CL A (VTVT) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering VTV THERAPEUTICS INC- CL A (VTVT) is 9.